阿尔茨海默病中的种子活动:特征,因素和应用
Yajie Liu1, Yuxiong Chen2, Ziyi Chen1
1Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Journal of Alzheimer's disease : JAD
|September 17, 2025
概括
种植活动 (TSA) 为阿尔茨海默病 (AD) 的诊断和监测提供了一个动态的生物标志物. 这种类似子的机制显示出早期检测和个性化治疗策略在阿尔茨海默病和相关病变的前景.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 错误折叠的蛋白质的类播种活动 (SA) 驱动着阿尔茨海默病 (AD) 的进展.
- 目前的AD诊断依赖于静态tau水平,限制了早期检测和动态监测.
- 的播种活动 (TSA) 是一个动态的生物标志物,反映了病态的聚和传播.
研究的目的:
- 审查tau结构,功能和SA机制,包括翻译后修改影响.
- 突出目前在阿尔茨海默病诊断中的静态生物标志物的局限性.
- 提出TSA作为早期AD诊断,风险评估和精准医学的综合生物标志物.
主要方法:
- 对有关蛋白结构,功能和播种活动的现有文献的综述.
- 对tau SA和传播背后的机制的分析.
- 讨论当前的诊断局限性和TSA的潜力.
主要成果:
- SA是一种类似的机制,对AD神经病理进展至关重要.
- TSA提供了一个动态测量病理,优于静态定量标记.
- 标准化的TSA检测和临床验证是其翻译潜力的必要条件.
结论:
- 酸盐是早期阿尔茨海默病诊断,风险分层和监测疾病进展的有希望的生物标志物.
- 将TSA与其他生物标志物的整合可以创建个性化的AD治疗的多维框架.
- 进一步的研究和标准化至关重要,以充分利用TSA在AD和病的临床实践中.
更多相关视频
05:54Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024
2.0K
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.7K
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
Dementia
526
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
526
